ArticleCurrent cancer drug targets2010

Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy.

Asfar S Azmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.